Events

Controlled Correspondence with FDA – An Update

Controlled Correspondence with FDA – An Update

The US Food and Drug Administration (FDA) has recently finalized its guidance to generic drug manufacturers on how to seek drug development information through the controlled correspondence (CC) process. This guidance finalizes the draft guidance issued in Nov 2017 and replaces the finalized guidance issued in September 2015. This update on controlled correspondence with FDA …

Controlled Correspondence with FDA – An Update Read More »